The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This policy watch provides a short overview of the Department of Health and Human Services (HHS), describing its history, budget, organizational structure and its major programs and responsibilities.
Private enrollment websites that are run by insurance companies typically only show plans offered by that insurer. Websites run by insurance brokers are required to show all plans offered by multiple insurers. If you have questions or concerns about information on these sites, contact the Marketplace call center, HealthCare.gov, or your state Marketplace. Many private enrollment websites also sell short-term health plans, cancer-only policies, and other less comprehensive products. These products may appear cheaper than…
The KFF-Washington Post partnership Survey of Parents explores experiences and views pertaining to childhood vaccines. The Survey of Parents also sheds light on school vaccination requirements, views on federal health agencies and policy changes, and the views of parents with children diagnosed with autism spectrum disorder. This poll comes as the Trump administration revamps federal policies, and HHS Secretary Robert F. Kennedy Jr. continues to question the childhood vaccine schedule.
This Health Policy 101 chapter explores Medicaid, the primary U.S. program providing comprehensive coverage of health care and long-term services and supports to about 80 million low-income people. Originating in 1965 and expanding with the Affordable Care Act, the chapter reviews Medicaid's evolution, including 2025 changes, and its joint federal and state financing and administration. It discusses how state-level flexibility in managing Medicaid leads to variation in coverage, spending, health care delivery, and access across…
This brief analyzes federal transparency data published by CMS on claims denials and appeals for Marketplace plan offered on HealthCare.gov in 2024, and finds insurers denied 19% of in-network claims. Consumers rarely appeal denied claims.
This brief focuses on consumers’ understanding of health insurance costs and examines existing federal protections that seek to address barriers to understanding the cost of coverage and care, such as price transparency, self-service price estimator tools, and simplifying cost-sharing designs.
This brief explains current Medicaid cost sharing rules and changes made to cost sharing rules by the 2025 reconciliation law, reports on cost sharing amounts states currently impose on ACA expansion adults, and highlights literature on the impact of cost sharing.
This Monitor covers how fears about fluoride as a neurotoxin are impacting public health and how trust in food safety is eroding following the USDA's disbandment of two food safety panels. It also discusses approaches to addressing false information and the accuracy of AI chatbots compared to search engines.
This volume examines how the cancellation of contracts to develop a bird flu vaccine and unfounded claims by new vaccine advisors reflect persistent myths about the safety of mRNA technology. It also explores false claims linking COVID-19 vaccines to miscarriage and analyzes how reactions to a Supreme Court ruling on gender-affirming care for minors highlights misconceptions and inflammatory language.
This post was updated to clarify that less than 10% of the nation's total health spending is spent on retail prescription drugs and does not include spending on drugs administrated by physicians or in hospitals.Prescription drug costs are a top concern for the American public. While retail prescription drugs represent less than 10% of total U.S. health spending and are not the primary driver of the nation’s high health costs, Americans often pay more for…
© 2026 KFF